VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$87.44M
Shares
17.18M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding VRCA
14 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 135,937 | $719,107 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 61,808 | $356,014 | 0.00% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 52,821 | $279,423 | 0.00% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 20,514 | $118,161 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 17,055 | $98,237 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 10,929 | $62,951 | 0.00% | Long | 2026-05-31 | |
| Dimensional U.S. Small Cap ETF | — | 7,373 | $46,966 | 0.00% | Long | 2026-04-30 | |
| Small Cap Core Fund | — | 1,607 | $8,501 | 0.00% | Long | 2026-03-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 800 | $5,096 | 0.00% | Long | 2026-04-30 | |
| Avantis Total Equity Markets ETF | — | 481 | $2,771 | 0.00% | Long | 2026-05-31 | |
| Small-Mid Cap Equity Fund | MSLC | 1,000 | $1,280 | 0.00% | Long | 2024-11-30 | |
| Total Stock Market Index Trust | — | 198 | $1,047 | 0.00% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 90 | $476 | 0.00% | Long | 2026-03-31 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 42 | $265 | 0.00% | Long | 2026-04-30 |
Showing 1–14 of 14 positions
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
42 filings
42 filers
Visit website
Investor relations